✦ LIBER ✦

Phase II clinical trial of VP-16-213 (etoposide) administered orally in advanced ovarian cancer

✍ Scribed by Flemming Hansen; Inger Malthe; Hans Krog

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of VP-16-213 in advanced

✍ Brian L. Hillcoat; J.J. Campbell; Roger Pepperell; Michael A. Quinn; James F. Bi 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 304 KB

cis-platinum (DDP) and VP 16-213 (etopos

✍ Mitrou, P.S.; Graubner, M.; Berdel, W.E.; Mende, S.; Gropp, C.; Diehl, V.; Klipp 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 490 KB

Phase II study of VP 16-213 (etoposide)

✍ B. A. J. Ponder; R. T. D. Oliver 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 227 KB

Phase II study of oral VP-16-213 in smal

✍ Yasaku Matsui; Shunsaku Oshima; Masao Kado; Masahiko Nakayama; Kaoru Shimokata; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views

A phase II study of oral VP-16-213 in no

✍ F. Cavalli; O. Klepp; J. Renard; M. Röhrt; P. Alberto 📂 Article 📅 1981 🏛 Elsevier Science ⚖ 386 KB

Phase II trial with weekly cisplatin (CD

✍ Lopez, R.; Fernandez, R.; Virizuela, J.A.; Cueva, J.; Garcia, E.; Sanz, A.; Vale 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB